A recent study by Zhu et al. (2020) demonstrated that trehalose administration attenuates mitochondrial dysfunction through activating transcriptional factor EB (TFEB)-mediated autophagy and mitophagy in cisplatin-induced AKI in vitro and in vivo. The gene discussed is TFEB; the disease is acute kidney injury.